A detailed history of Linker Capital Management Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Linker Capital Management Inc. holds 3,947 shares of ABT stock, worth $452,957. This represents 0.56% of its overall portfolio holdings.

Number of Shares
3,947
Previous 5,663 30.3%
Holding current value
$452,957
Previous $573,000 24.96%
% of portfolio
0.56%
Previous 0.63%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $172,938 - $192,689
-1,716 Reduced 30.3%
3,947 $430,000
Q4 2021

Jan 21, 2022

BUY
$115.53 - $141.46 $654,246 - $801,087
5,663 New
5,663 $797,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $201B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Linker Capital Management Inc. Portfolio

Follow Linker Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Linker Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Linker Capital Management Inc. with notifications on news.